Clinical Research Directory

Inclusion Criteria: * Patients older than 18 years and under 75 years * Informed consent signed * ASA I, II and III * Patient affiliated to social security Exclusion Criteria: * ASA IV * BMI\> 35 kg / m * Personal or family history of malignant hyperthermia * History of allergy or hypersensitivity to intravenous anesthetics (remifentanil), local anesthetics or muscle relaxants * Contraindications to sevoflurane: a history of malignant hyperthermia, history of liver disease after sevoflurane anesthesia, halogenated agents or hypersensitivity to any of these components. * Contraindications to succinylcholine: hyperkalemia, plasma cholinesterase deficiency nickname, para or tetraplegia more than 24 hours, burns over 24 * Contraindications to cisatracurium: myasthenia * Neuromuscular diseases * Contraindications to local anesthetics: hypersensitivity to local anesthetics of the amide, intravenous regional anesthesia, porphyria, ventricular atrial conduction disturbances, epilepsy uncontrolled by treatment * Pregnancy and lactation * severe coagulation disorders * Inability to understand and give informed consent * Patient under guardianship, curatorship or protected * Indication of use of a hypnotic ketamine (BIS change)